1 / 76

Region X SOP Equipment, Drugs, Skills

Region X SOP Equipment, Drugs, Skills. October 2011 CE Condell Medical Center EMS System Site Code #107200E-1211. Prepared by: Sharon Hopkins, RN, BSN, EMT-P. Objectives. Upon successful completion of this module, the EMS provider will be able to: Review the changes to the Region X SOP’s

uta
Download Presentation

Region X SOP Equipment, Drugs, Skills

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Region X SOP Equipment, Drugs, Skills October 2011 CE Condell Medical Center EMS System Site Code #107200E-1211 Prepared by: Sharon Hopkins, RN, BSN, EMT-P

  2. Objectives Upon successful completion of this module, the EMS provider will be able to: • Review the changes to the Region X SOP’s • Discuss the action, indications, contraindications, dosing, and side effects of Atrovent (Ipratropium), Etomidate, Fentanyl, and Zofran (Ondansetron) • Given equipment, demonstrate appropriate use of the humeral site for IO insertion • Given equipment, demonstrate placement of the King airway • Actively participate in case scenario presentations • Complete the 10 question pre quiz

  3. Atrovent (Ipratropium Bromide)Actions • Bronchodilation of bronchial smooth muscle • Blocks action of acetycholine at parasympathetic sites in bronchial smooth muscle (an anticholinergic drug) • Will dry up excessive secretions • Onset 5 - 15 minutes • Duration 4 - 6 hours

  4. Atrovent (Ipratropium Bromide) Indications • Treatment of bronchospasm due to asthma, COPD, bronchitis, emphysema • Not used for immediate relief but for maintenance of effects from bronchospasm • Therefore helpful when mixed with Albuterol • Albuterol used for the rescue, Atrovent for the longer effects • If taken at home, can be repeated by EMS upon their arrival

  5. Atrovent (Ipratropium Bromide)Contraindications • Hypersensitivity to atropine • No age-related precautions • Children and elderly • Unknown if passes through to breast milk • Peanut allergies are related to the metered dose prescription; not the product used in Region X

  6. Atrovent (Ipratropium Bromide) Dosing • Adult and peds • 0.5mg / 2.5 mL ampule • To be mixed with Albuterol in nebulizer cup • First dose only; Albuterol alone after first dose

  7. Atrovent (Ipratropium Bromide)Side Effects • Coughing • Dizziness • Insomnia, restlessness • Nausea • Dry mouth • Headache

  8. Etomidate Actions • Nonbarbiturate hypnotic, sedative • Short acting drug to produce rapid anesthesia • Minimal cardiovascular effects • Onset 1 - 2 minutes • Duration generally 3 - 5 minutes

  9. Etomidate Indications • Sedation to relieve apprehension or impair memory during intubation • Effects may be increased when combined with other central nervous system (CNS) depressants

  10. Etomidate Contraindications • Hypersensitivity to Etomidate • Labor and delivery • Insufficient data to support its use • Contact Medical Control for clarification

  11. Etomidate Dosing • Adult and peds • 0.3 mg/kg slow IVP/IO • Give over 30-60 seconds • Maximum dose 20 mg • Typical 150 pound person meets the max of 20mg • Too rapid an injection may result in hypotension • Treat with fluid challenge • 0.3 mg is an average dose • Dosing charts for adults and peds available in SOP’s

  12. Etomidate Side Effects • Nausea and vomiting • Dysrhythmias • Breathing difficulties • Hypotension – treat with fluids • Hypertension • Transient involuntary muscle movement • Myoclonic activity (coughing, hiccups) • Appears as muscle twitching especially if given too rapidly • Usually resolves spontaneously, does not interfere with ability to finish securing the airway • Pain at injection site • Less when larger, more proximal sites used

  13. Fentanyl Actions • Opioid analgesic • Alters pain reception • Increases pain threshold • Also known as • Duragesic • Onset 7-8 minutes • Duration ½ - 1 hour

  14. Fentanyl Indications • Sedation • Pain relief • Adjunct to general or regional anesthesia • In cardioversion, Versed (midazolam) used for the initial sedation and as an amnesic • Fentanyl used for any pain/discomfort

  15. Fentanyl Contraindications • Increased intracranial pressure (ICP) • Severe hepatic (liver) or renal impairment • Severe respiratory depression • Cautious use in bradycardia • Readily crosses the placenta • May prolong labor if given in first stage of labor or before cervical dilation of 4-5 cm

  16. Fentanyl Dosing • Adult and peds • 0.5 mcg/kg slow IVP/IN/IO • Administer over 1-2 minutes • IN route must be a rapid delivery to create a mist • Too rapid administration increases risk of skeletal and thoracic muscle rigidity resulting in larygo and broncho spasms and apnea • May repeat 0.5 mcg/kg slow IVP/IN/IO in 5 minutes • IN route must be delivered rapidly to create a mist • Max total dose is 200 mcg adult and pediatrics

  17. Fentanyl Side Effects • Mixing with benzodiazepines may increase risk of hypotension and respiratory depression • Narcan an effective reversal agent • BVM should be available when medications that can cause respiratory depressant are being administered • Nausea, vomiting, diarrhea, constipation • Less nausea noted than with use of Morphine • Dry mouth • Abdominal pain • Orthostatic hypotension

  18. Zofran (Ondansetron) Actions • Antinausea, antiemetic • Half-life 3 – 6 hours

  19. Zofran (Ondansetron)Indications • Prevention/treatment of nausea and/or vomiting

  20. Zofran (Ondansetron) Contraindications • Hypersensitivity to the medication • Caution: • A 9/15/11 FDA Medwatch Safety Alert issued for patients with long QT syndrome • May develop tachydysrhythmia (i.e.; Torsades) • Watch for dysrhythmias • Patient may complain of a racing feeling • Palpate the pulse and compare with the initial assessment

  21. Zofran (Ondansetron) Dosing • Adult 4 mg IVP/IO over 30 seconds • Peds <40 kg 0.1 mg/kg IVP/IO over 30 seconds • Peds >40 kg 4 mg IVP/IO over 30 seconds • May repeat once after 10 minutes

  22. Zofran (Ondansetron) Side Effects • Anxiety • Dizziness • Drowsiness – especially noted in children • Headache • Fatigue • Constipation, diarrhea • Hypoxia • Urinary retention

  23. The King Airway • Alternate airway device • Supraglottic, supralaryngeal, extraglottic, oropharyngeal • Back up for failed or difficult intubation attempts in the field • Provides a ventilatory device

  24. King Airway • A dual lumen supraglottic airway • 2 cuffs inflated with a single valve • Device sits in the larynx above the vocal cords • Distal cuff seals esophagus • Proximal cuff seals oropharynx • Throat at the back of the mouth Balloons inflated

  25. King Airway Contraindications • Persons less than 4 feet tall • Presence of a gag reflex • Check for presence of a blink reflex • Stroke eye lashes looking for eye movement • Tap space between eyes at bridge of nose to check for blink reflex • Known esophageal disease • Caustic ingestion

  26. Sizing • Choose color-coded size based on patient height • 4-5' tall – size 3 – yellow • Think “3-4-5” • 5-6' tall – size 4 – red • Think “4-5-6” • >6' tall – size 5 – purple • Think “5-6”

  27. Procedure • Pre-oxygenate patient via BVM • May need to insert an oropharyngeal airway (OPA) or nasopharyngeal airway (NPA) • Pre-oxygenate for 3 minutes • Prepare to remove airway adjunct just prior to insertion of King airway

  28. Procedure cont’d • Assemble and check equipment • King airway • Syringe • Water-soluble lubricant • BVM • Stethoscope • Device/tape to secure tube

  29. Procedure cont’d • Lubricate back side of tip of King airway • Avoid lubricant in ventilation ports • With non-dominate hand, hold mouth open and apply chin lift • Must use a chin lift to facilitate passing the device • In the presence of trauma, manual control of the c-spine needs to be simultaneously performed • Hold King airway at connector with dominant hand

  30. Procedure cont’d • Using lateral approach, introduce tip into patient’s mouth • Blue orientation line should be touching corner of mouth • Advance tip behind base of tongue while rotating tube to midline • Blue orientation line faces chin of patient

  31. Procedure cont’d • Without excessive force, advance tube until base of colored connector is aligned with patient's teeth or gums • Tube must be inserted all the way in, cuffs inflated, and then withdrawn into correct position

  32. Procedure cont’d • Inflate pilot balloon with appropriate volume of air • Inflate using the minimum volume of air posted • Ranges printed on side of tube as reference • Size 3 (yellow) – 45 - 60 mL • Size 4 (red) – 60 – 80 mL • Size 5 (purple) – 70 -90 mL • Remove syringe while holding down plunger to avoid pulling air out of cuffs

  33. Procedure cont’d • While bagging, gently and simultaneously withdraw King airway until breath sounds are auscultated and ventilation is easier • Adjust cuff inflation if necessary if air leak is heard

  34. Procedure cont’d • Confirm device placement • 5 point auscultation • Negative epigastric sounds • Bilateral breath sounds • Equal rise and fall of chest • ETCO2 yellow or capnography 35-40 mm Hg • Apply cervical collar to assist in maintaining tube position

  35. Nice to Know! • “…no inadvertent tracheal intubation, which would lead to complete obstruction of the airway occurred. • Genzwuerker H et al. The Laryngeal Tube: A New Adjunct for Airway Management. Prehosp Emerg Care 2000; 4(2): 168-72.

  36. King Airway Insertion Tips • Use a chin lift and lateral approach • Facilitates placement of distal tip around posterior pharynx and under base of tongue • Keep tip and tube midline • If advanced laterally, tip may enter a blind pouch (pyriform fossa) and bounce back during inflation

  37. King Airway Insertion Tips • Insertion depth MUST be adjusted to maximize ventilation • Best insertion depth is to place colored adapter at teeth or gum line, inflate cuffs and withdraw until ventilations adequate

  38. Documentation King Airway • Size King airway used • Confirmation method • Rate of ventilations provided • One breath every 6 seconds • Works for patients with or without a pulse • Works for the patient receiving CPR • Can write the word “King” in space next to “ET” and finish documentation in notes section

  39. EZ IO • The alternative IV access method • Rapid placement • Rapid entry into the bloodstream • Consider if patient NEEDS IV access or do YOU just want IV access? • Remember in the patient with a stroke • Minimize IV sticks – they’ll be receiving fibrinolytics that will affect clotting time

  40. Highlights on EZ IO Needles • Avoid prejudicing decisions of needle size to patient population • No longer referring to “pink=peds”, “adult” and “bariatric” needles • Needles referred to by their length • 15mm (pink), 25mm (blue), and 45mm (yellow) • Half of peds needs a 15mm needle and half need 25mm • Determine needle length needed by palpating over the site • Let the drill pull itself in, don’t push the needle in • Stop drilling when loss of resistance is felt

  41. EZ IO Needles • Note the black identifying line mark on each needle • Need to keep at least one black line visible once needle touches bone and prior to drilling

  42. EZ IO Needle Sizing • Insert needle tip into site until resistance is felt • The needle tip is touching bone • If at least one black mark is still visible, there is enough needle length remaining to secure into the site

  43. EZ IO 45 mm Yellow Needle • Used for obesity over the landmark site • Some patients may be large in select areas of their body but not in their extremities • Think of the patient with COPD • Palpation and clinical judgment used

  44. EZ IO 45mm Needle • Recommended for the humeral site in all patients over 40 kg (88 pounds) • A back-up site alternative to the tibial site • Humerus a relatively softer bone • Not a weight bearing bone • Longer needle provides more stability in the bone • Aim needle in slightly inferior (downward) direction • Imagine the tip moving toward the arm socket or toward an imagined space between the heart and the spine • Immobilize the arm after IO insertion to avoid dislodging needle

  45. Palpating the Humeral Head G = greater tuberosity L = lesser tuberosity M = metaphysis Target site is the greater tuberosity

  46. Humeral IO Insertion Site • Adduct patient's arm over their abdomen • In supine patient, elbow pulled back, resting on the bed/backboard,/ground makes this site more prominent • Push your thumb into humerus about mid-shaft, palpate up the humerus until you feel the bone bow out • This is the surgical neck • Continue to palpate up about 1 finger width (1 cm) • This will be the center of the greater tubercle of the humerus

  47. Humeral IO Insertion Site Alternate identification of site: • Hit your palm on anterior portion of the shoulder • You feel a golf ball sized bone in the natural indentation of your palm • This is the greater tubercle which is just anterior to midline • To find midline, square up the shoulder and visualize where the middle is

  48. Humeral IO Insertion Site Alternate identification of site: • Gently lift arm straight up via the elbow • Keep arm and elbow next to body • Lift up like trying to touch the shoulder to patient's ear • Proximal humerus very pronounced and easy to identify

  49. Humeral IO Site • As a non-weight bearing bone, humerus softer than tibia • Will need to immobilize arm to prevent movement • Secure IV site to avoid inadvertent needle removal

More Related